Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02381067 · ClinicalTrials.gov registry record · NA
A Prospective Study of NuCel® in Cervical Spine Fusion
A NA study, sponsored by NuTech Medical.
- Terminated
- Registry status
- NA
- Development phase
- 61
- Enrollment target
NCT02381067: Clinical Trial NA study, sponsored by NuTech Medical.
NCT02381067 is a NA study that was terminated before completion, run by NuTech Medical. The registered enrollment target is 61 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02381067, a NA study, was terminated before completion, sponsored by NuTech Medical.
- TERMINATED
- Registry status
- NA
- Development phase
- 61 participants
- Enrollment target
Study Summary
The study is intended to demonstrate that the NuCel® allograft is effective and safe in promoting bone growth and fusion rate when used in cervical fusion in patients with one, two or three-level diseases of the cervical spine.
Primary Outcome
Interbody fusion will be measured using CT scans and standard radiographs
Interventions
- OTHER NuCel with Allograft Bone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2015-03 |
| Est. Completion | 2016-12-15 |
| Phase | NA |
Why NCT02381067 stopped before completion
NCT02381067 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 61 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 1 intervention - of which NuCel with Allograft Bone is the first listed.
NCT02381067 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02381067 about?
NCT02381067 is a clinical study titled "A Prospective Study of NuCel® in Cervical Spine Fusion". The study is intended to demonstrate that the NuCel® allograft is effective and safe in promoting bone growth and fusion rate when used in cervical fusion in patients with one, two or three-level diseases of the cervical spine.
What is the current status of trial NCT02381067?
This trial is currently terminated. It is a NA study. The enrollment target is 61 participants. The study started on 2015-03. Estimated completion is 2016-12-15.
What interventions are being tested in trial NCT02381067?
The interventions under investigation include: NuCel with Allograft Bone (OTHER).
Who is sponsoring clinical trial NCT02381067?
This trial is sponsored by NuTech Medical, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02381067's enrollment target sits among peer trials
61 1164th of 2000 higher than 837 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04115306 · 61 participants · Phase 1
Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer
- NCT05070845 · 61 participants · Phase 2
Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia
- NCT05187832 · 61 participants · Phase 1
A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer
- NCT05269316 · 61 participants · Phase 1
Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia